Afficher la notice abrégée

dc.creatorFotakopoulos G., Fountas K., Tsianaka E., Kotlia P., Pachatouridis D., Paschalis T., Voulgaris S.en
dc.date.accessioned2023-01-31T07:38:22Z
dc.date.available2023-01-31T07:38:22Z
dc.date.issued2018
dc.identifier10.4155/fsoa-2017-0103
dc.identifier.issn20565623
dc.identifier.urihttp://hdl.handle.net/11615/71669
dc.description.abstractAim: To evaluate the possible superiority of outcome in patients with elevated IGF-I levels after vestibular schwannoma (VS) resection. Patients & methods: This retrospective study included 65 patients (34 male, 52.3%) with VS operated in between January 2009 and April 2014 (follow-up 3.2 ± 0.7 years). Preoperative or postoperative IGF-I levels were identified for each patient. Results: Patients were divided into two groups: Group A (small size tumor), 56 patients; and Group B (large size tumor), 9 cases. IGF-I levels in Group A (195.8 ± 32.9 ng/ml) were compared with those of Group B (242.2 ± 22.2 ng/ml) and were found to have statistically significant difference (p = 0.001). Conclusion: Increased IGF-I levels could hold a key role in nerve recovery in patients undergoing surgical resection of large VS. Lay abstract The aim of this study was to examine the possible correlation between IGF-I levels in serum in large vestibular schwannomas (VS) and its potential neuroprotective effect on the vestibulocochlear nerve. This retrospective study included 65 patients that underwent surgery, 9 of whom were diagnosed with large VS. Results suggested that elevated IGF-I in serum levels could help identify patients with large VS with better neuroprotective activity. © 2018 2017 George Fotakopoulos.en
dc.language.isoenen
dc.sourceFuture Science OAen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85069007672&doi=10.4155%2ffsoa-2017-0103&partnerID=40&md5=2c8710cd785b8e4ec459c80956b17836
dc.subjectsomatomedin C receptoren
dc.subjectacoustic neuromaen
dc.subjectadulten
dc.subjectageden
dc.subjectArticleen
dc.subjectcomputer assisted tomographyen
dc.subjectenzyme linked immunosorbent assayen
dc.subjectfacial nerve injuryen
dc.subjectfemaleen
dc.subjectgrowth hormone releaseen
dc.subjecthistopathologyen
dc.subjecthumanen
dc.subjectlength of stayen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectnerve regenerationen
dc.subjectneurologic examinationen
dc.subjectneuroprotectionen
dc.subjectpriority journalen
dc.subjectreceiver operating characteristicen
dc.subjectretrospective studyen
dc.subjectsensitivity and specificityen
dc.subjecttumor volumeen
dc.subjectvestibulocochlear nerveen
dc.subjectFuture Medicine Ltd.en
dc.titleCould IGF-I levels play a neuroprotective role in patients with large vestibular schwannomas?en
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée